Correlation Between Psyence Biomedical and Dermata Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Psyence Biomedical and Dermata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Psyence Biomedical and Dermata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Psyence Biomedical Ltd and Dermata Therapeutics, you can compare the effects of market volatilities on Psyence Biomedical and Dermata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Psyence Biomedical with a short position of Dermata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Psyence Biomedical and Dermata Therapeutics.

Diversification Opportunities for Psyence Biomedical and Dermata Therapeutics

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between Psyence and Dermata is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Psyence Biomedical Ltd and Dermata Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dermata Therapeutics and Psyence Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Psyence Biomedical Ltd are associated (or correlated) with Dermata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dermata Therapeutics has no effect on the direction of Psyence Biomedical i.e., Psyence Biomedical and Dermata Therapeutics go up and down completely randomly.

Pair Corralation between Psyence Biomedical and Dermata Therapeutics

Considering the 90-day investment horizon Psyence Biomedical Ltd is expected to generate 1.19 times more return on investment than Dermata Therapeutics. However, Psyence Biomedical is 1.19 times more volatile than Dermata Therapeutics. It trades about -0.2 of its potential returns per unit of risk. Dermata Therapeutics is currently generating about -0.26 per unit of risk. If you would invest  345.00  in Psyence Biomedical Ltd on August 17, 2025 and sell it today you would lose (74.00) from holding Psyence Biomedical Ltd or give up 21.45% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Psyence Biomedical Ltd  vs.  Dermata Therapeutics

 Performance 
       Timeline  
Psyence Biomedical 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Psyence Biomedical Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental drivers, Psyence Biomedical is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Dermata Therapeutics 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Dermata Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in December 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Psyence Biomedical and Dermata Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Psyence Biomedical and Dermata Therapeutics

The main advantage of trading using opposite Psyence Biomedical and Dermata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Psyence Biomedical position performs unexpectedly, Dermata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermata Therapeutics will offset losses from the drop in Dermata Therapeutics' long position.
The idea behind Psyence Biomedical Ltd and Dermata Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities